Feasibility Study to Use Biosensing Devices to Monitor PA and Resp. Function in Smokers w and w/o Resp. Symptoms/COPD

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

27 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-07

Study Completion Date

2019-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines the feasibility and acceptability of using mobile applications and biosensing (mHealth) devices in detecting vitality parameters in current smokers with and without respiratory symptoms/COPD (e.g., heart rate, blood oxygenation, steps/motion) for a future big-scale study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)

NCT05776654

Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Exacerbation

COMPLETED

Standardized Home Spirometry Method in Normal Population

NCT03945500

Mobile Applications Healthy Volunteers Feasibility Study

COMPLETED NA

The Effect of Use of Breathing Exercise Device and Reading Aloud on Vital Signs

NCT04978831

Chronic Obstructive Pulmonary Disease Breath Shortness

COMPLETED NA

Early Warning Value of Consumer Wearable Devices in AECOPD

NCT05974670

COPD

UNKNOWN

Feasibility Study of a Non-invasive Device to Quickly, Easily and Accurately Measure Respiration in a Clinical Setting

NCT04182711

COPD

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is designed to investigate feasibility of using mHealth devices to improve the treatment, assessment, compliance, and outcomes in smokers with and without respiratory symptoms/COPD. The study aims to reveal and address the anticipated barriers to the acceptance and implementation of mHealth devices in this patient population and clinical setting. As is well documented, the more attention patients receive from medical personnel, the better their clinical outcomes. Here we are attempting to use device-driven monitoring applications, interactive reminders, and teaching modules to deliver a constant positive feedback loop to patients to improve their health decisions.

Objectives of the study:

To assess the feasibility of using mHealth devices in current smokers with and without respiratory symptoms/COPD.

To assess the utility (i.e., validity and reproducibility) of mHealth devices in detecting vitality parameters in current smokers with and without respiratory symptoms/COPD (e.g., heart rate; blood oxygenation; steps/motion; FEV1, FVC, and their ratio; peak expiratory flow \[PEF\]).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Signs and Symptoms, Respiratory Mobile Applications Activity Trackers Respiratory Function Tests

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Asymptomatic current smokers

No respiratory symptoms and preserved pulmonary function based on spirometry (FEV1/FVC of at least 0.70 after bronchodilation treatment and FVC ≥80% of the expected value)

Anamed OEM device; Air Next mobile spirometry device

Intervention Type DEVICE

Anamed OEM (Original Equipment Manufacturer) device - physical activity and vital signs monitoring; Air Next mobile spirometry device

"Grey zone" current smokers

Initially preserved pulmonary function based on spirometry, but with clinical symptoms based on COPD Assessment Test (CAT≥10) and results of the 6-min walk test (6 MWT) less than 450 meters.

Anamed OEM device; Air Next mobile spirometry device

Intervention Type DEVICE

Anamed OEM (Original Equipment Manufacturer) device - physical activity and vital signs monitoring; Air Next mobile spirometry device

Current smokers with COPD

Current smokers with a confirmed diagnosis of COPD (GOLD stage I-III)

Anamed OEM device; Air Next mobile spirometry device

Intervention Type DEVICE

Anamed OEM (Original Equipment Manufacturer) device - physical activity and vital signs monitoring; Air Next mobile spirometry device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anamed OEM device; Air Next mobile spirometry device

Anamed OEM (Original Equipment Manufacturer) device - physical activity and vital signs monitoring; Air Next mobile spirometry device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current smokers who are currently smoking conventional cigarettes with a minimum of 10 pack-year smoking history
* Able to use and willing to be trained to use mHealth devices

Exclusion Criteria

* COPD exacerbation that has not resolved at least 28 days prior to screening
* COPD exacerbation occurring after screening but before the first study visit
* Pneumonia or other respiratory tract infections that have not resolved at least 14 days prior to screening
* Pneumonia occurring after screening but before the first study visit
* Active respiratory disorders: tuberculosis, lung cancer, significant bronchiectasis, sarcoidosis, bronchial asthma, lung fibrosis, pulmonary hypertension, interstitial lung diseases, or other active pulmonary diseases
* Any co-morbid medical condition that in the opinion of the investigator would make participation in the study unsafe or unfeasible, including conditions that prohibit completion of exercise testing
* Use of supplemental oxygen therapy
* Inability to abstain from smoking during the period in which the participant is admitted to the Kazakhstan Academy of Preventive Medicine (KAPM) COPD Center
* A history of allergy or hypersensitivity to metal, particularly stainless steel
* Any vital sign indicator, for example, hypertension or tachycardia at rest that, at the discretion of the investigator, would make participation in the study unsafe or unfeasible
* Women who test positive for pregnancy during screening, lactating women, or women planning on becoming pregnant during the study
* Participants using assistive devices like walking aids, as these are likely to interfere with physical activity

Minimum Eligible Age

40 Years

Maximum Eligible Age

59 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes